688265 南模生物
已收盘 06-11 15:00:01
资讯
新帖
简况
每周股票复盘：南模生物（688265）董事拟减持不超0.0032%股份
证券之星 · 06-07
每周股票复盘：南模生物（688265）董事拟减持不超0.0032%股份
破发股南模生物某技术拟减持 2021上市即巅峰募16.5亿
中金财经 · 06-03
破发股南模生物某技术拟减持 2021上市即巅峰募16.5亿
南模生物（688265）披露董事减持股份计划公告，6月2日股价下跌2.39%
证券之星 · 06-02
南模生物（688265）披露董事减持股份计划公告，6月2日股价下跌2.39%
每周股票复盘：南模生物（688265）完成32.672万股限制性股票归属
证券之星 · 05-31
每周股票复盘：南模生物（688265）完成32.672万股限制性股票归属
南模生物（688265）披露2025年限制性股票激励计划首次授予部分第一个归属期第一批归属结果公告，5月26日股价下跌2.49%
证券之星 · 05-26
南模生物（688265）披露2025年限制性股票激励计划首次授予部分第一个归属期第一批归属结果公告，5月26日股价下跌2.49%
每周股票复盘：南模生物（688265）2025年年度股东会多项议案获通过
证券之星 · 05-24
每周股票复盘：南模生物（688265）2025年年度股东会多项议案获通过
南模生物（688265）披露2025年年度股东会决议公告，5月18日股价下跌0.28%
证券之星 · 05-18
南模生物（688265）披露2025年年度股东会决议公告，5月18日股价下跌0.28%
每周股票复盘：南模生物（688265）Q1净利同比增170.71%
证券之星 · 05-02
每周股票复盘：南模生物（688265）Q1净利同比增170.71%
南模生物（688265）2026年一季报简析：营收净利润同比双双增长，盈利能力上升
证券之星 · 05-01
南模生物（688265）2026年一季报简析：营收净利润同比双双增长，盈利能力上升
南模生物（688265）披露2026年第一季度报告，4月30日股价下跌0.05%
证券之星 · 04-30
南模生物（688265）披露2026年第一季度报告，4月30日股价下跌0.05%
南模生物(688265)3月31日股东户数0.68万户，较上期增加2.58%
证券之星 · 04-29
南模生物(688265)3月31日股东户数0.68万户，较上期增加2.58%
南模生物（688265）披露2025年度利润分配方案的公告，4月27日股价下跌1.93%
证券之星 · 04-27
南模生物（688265）披露2025年度利润分配方案的公告，4月27日股价下跌1.93%
股市必读：南模生物年报 - 第四季度单季净利润同比下降78.46%
中金财经 · 04-27
股市必读：南模生物年报 - 第四季度单季净利润同比下降78.46%
图解南模生物年报：第四季度单季净利润同比下降78.46%
证券之星 · 04-26
图解南模生物年报：第四季度单季净利润同比下降78.46%
每周股票复盘：南模生物（688265）审议2026年员工持股计划
证券之星 · 04-19
每周股票复盘：南模生物（688265）审议2026年员工持股计划
南模生物（688265）披露2026年员工持股计划相关议案获临时股东会通过，4月15日股价下跌0.02%
证券之星 · 04-15
南模生物（688265）披露2026年员工持股计划相关议案获临时股东会通过，4月15日股价下跌0.02%
南模生物：2025年度净利润同比增长399.29%
每日经济新闻 · 02-27
南模生物：2025年度净利润同比增长399.29%
南模生物：预计2025年全年扣非后净利润盈利650万元至950万元
证券之星 · 01-29
南模生物：预计2025年全年扣非后净利润盈利650万元至950万元
南模生物跌3.17% 2021年上市即巅峰募16.5亿元
中金财经 · 01-22
南模生物跌3.17% 2021年上市即巅峰募16.5亿元
每周股票复盘：南模生物（688265）现溢价13.95%大宗交易
证券之星 · 01-18
每周股票复盘：南模生物（688265）现溢价13.95%大宗交易
加载更多
公司概况
公司名称：
上海南方模式生物科技股份有限公司
所属行业：
研究和试验发展
上市日期：
2021-12-28
主营业务：
上海南方模式生物科技股份有限公司的主营业务是基因修饰动物模型的研发、生产、销售和技术服务业务。公司的主要产品是定制化模型、标准化模型、模型繁育、药物评价及表型分析、饲养服务。
发行价格：
84.62
{"stockData":{"symbol":"688265","market":"SH","secType":"STK","nameCN":"南模生物","latestPrice":31.56,"timestamp":1781161201000,"preClose":31.92,"halted":0,"volume":396735,"delay":0,"changeRate":-0.0113,"floatShares":77963500,"shares":77963500,"eps":0.4244,"marketStatus":"已收盘","change":-0.36,"latestTime":"06-11 15:00:01","open":32.2,"high":32.2,"low":30.81,"amount":12440100,"amplitude":0.0435,"askPrice":31.56,"askSize":10,"bidPrice":31.43,"bidSize":4,"shortable":0,"etf":0,"ttmEps":0.4244,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1781227800000},"marketStatusCode":5,"adr":0,"adjPreClose":31.92,"symbolType":"stock_kcb","openAndCloseTimeList":[[1781141400000,1781148600000],[1781154000000,1781161200000]],"highLimit":35.11,"lowLimit":28.73,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":77963513,"isCdr":false,"pbRate":1.44,"roa":"--","peRate":74.363808,"roe":"0.04%","epsLYR":0.42,"committee":0.236181,"marketValue":2461000000,"turnoverRate":0.0051,"status":1,"afterMarket":{"amount":0,"volume":0,"close":31.56,"buyVolume":0,"sellVolume":0,"time":1781163238867,"indexStatus":"已收盘 06-11 15:30:00","preClose":31.92},"floatMarketCap":2461000000},"requestUrl":"/m/hq/s/688265","defaultTab":"news","newsList":[{"id":"2641127718","title":"每周股票复盘：南模生物（688265）董事拟减持不超0.0032%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2641127718","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641127718?lang=zh_cn&edition=full","pubTime":"2026-06-07 03:08","pubTimestamp":1780772893,"startTime":"0","endTime":"0","summary":"截至2026年6月5日收盘，南模生物报收于33.32元，较上周的35.23元下跌5.42%。本周关注点公司公告汇总：职工代表董事王津津拟减持不超2,500股，占公司总股本0.0032%公司公告汇总职工代表董事王津津女士直接持有公司股份10,000股，占公司总股本0.0128%，来源于股权激励。因个人资金需要，王津津计划通过集中竞价交易方式减持不超过2,500股，即不超过公司总股本的0.0032%，减持期间为2026年6月25日至2026年9月24日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060700001039.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688265","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640297260","title":"破发股南模生物某技术拟减持 2021上市即巅峰募16.5亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2640297260","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640297260?lang=zh_cn&edition=full","pubTime":"2026-06-03 16:14","pubTimestamp":1780474451,"startTime":"0","endTime":"0","summary":"中国经济网北京6月3日讯 南模生物 昨晚披露董事减持股份计划公告称，截至公告披露日，公司职工代表董事王津津直接持有公司股份10,000股，占公司总股本比例为0.0128%，来源于2025年限制性股票激励计划取得的股份，为无限售条件流通股。 因个人资金需要，王津津计划通过集中竞价交易方式减持其所持有的公司股份不超过2,500股，即不超过公司总股本的0.0032%。 南模生物首次公开发行股票的发行费用总额为1.81亿元，其中，保荐及承销费用1.58亿元。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202606/03/20260603849281.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202606/03/20260603849281.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260603/32268788.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0216","688265","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640941350","title":"南模生物（688265）披露董事减持股份计划公告，6月2日股价下跌2.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640941350","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640941350?lang=zh_cn&edition=full","pubTime":"2026-06-02 22:48","pubTimestamp":1780411697,"startTime":"0","endTime":"0","summary":"近日，南模生物披露《董事减持股份计划公告》。公告显示，截至公告披露日，公司职工代表董事王津津女士直接持有公司股份10,000股，占公司总股本0.0128%，来源于股权激励。因个人资金需要，王津津计划通过集中竞价交易方式减持不超过2,500股，即不超过公司总股本的0.0032%，减持期间为2026年6月25日至2026年9月24日。王津津此前已作出持股及减持承诺，本次减持计划与其一致。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200047603.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688265","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639360231","title":"每周股票复盘：南模生物（688265）完成32.672万股限制性股票归属","url":"https://stock-news.laohu8.com/highlight/detail?id=2639360231","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639360231?lang=zh_cn&edition=full","pubTime":"2026-05-31 04:48","pubTimestamp":1780174092,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘，南模生物报收于35.23元，较上周的38.66元下跌8.87%。南模生物当前最新总市值27.47亿元，在医疗服务板块市值排名46/51，在两市A股市值排名4653/5207。本次归属限制性股票数量为326,720股，来源为公司自二级市场回购的A股普通股股票，归属对象为75名激励对象，包括董事、高级管理人员及核心技术骨干。因1名激励对象自愿放弃2.00万股且2名激励对象未完成出资，实际首批归属数量由35.9320万股调整为32.6720万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026053100001508.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688265","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638453135","title":"南模生物（688265）披露2025年限制性股票激励计划首次授予部分第一个归属期第一批归属结果公告，5月26日股价下跌2.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638453135","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638453135?lang=zh_cn&edition=full","pubTime":"2026-05-26 22:55","pubTimestamp":1779807315,"startTime":"0","endTime":"0","summary":"截至2026年5月26日收盘，南模生物报收于37.15元，较前一交易日下跌2.49%，最新总市值为28.96亿元。公告显示，公司已完成2025年限制性股票激励计划首次授予部分第一个归属期第一批的股份归属登记。其中，孙瑞林、王津津分别归属2.00万股和1.00万股，其余73人合计归属29.672万股。因1名激励对象自愿放弃2.00万股且2名激励对象未完成出资，实际首批归属数量由35.9320万股调整为32.6720万股。公司已收到股票认购款共计4,204,886.40元，股份登记已于2026年5月26日完成。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052600041590.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688265"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637376440","title":"每周股票复盘：南模生物（688265）2025年年度股东会多项议案获通过","url":"https://stock-news.laohu8.com/highlight/detail?id=2637376440","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637376440?lang=zh_cn&edition=full","pubTime":"2026-05-24 05:12","pubTimestamp":1779570734,"startTime":"0","endTime":"0","summary":"公司公告汇总上海南方模式生物科技股份有限公司于2026年5月18日召开2025年年度股东会，会议审议通过2025年度董事会工作报告、2025年年度报告及其摘要、2025年度利润分配方案、续聘会计师事务所、董事及高管薪酬相关议案，以及对外出租部分闲置场地的议案。北京市通商律师事务所就上海南方模式生物科技股份有限公司2025年年度股东会的召集、召开程序、召集人和出席会议人员资格、表决程序及表决结果出具法律意见书。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052400001676.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688265","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636432074","title":"南模生物（688265）披露2025年年度股东会决议公告，5月18日股价下跌0.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636432074","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636432074?lang=zh_cn&edition=full","pubTime":"2026-05-18 22:36","pubTimestamp":1779114991,"startTime":"0","endTime":"0","summary":"截至2026年5月18日收盘，南模生物报收于39.28元，较前一交易日下跌0.28%，最新总市值为30.62亿元。该股当日开盘39.63元，最高39.63元，最低38.55元，成交额达1765.16万元，换手率为0.58%。近日，南模生物披露《2025年年度股东会决议公告》。公告显示，公司于2026年5月18日召开2025年年度股东会，会议审议通过了2025年度董事会工作报告、2025年年度报告及其摘要、2025年度利润分配方案、续聘会计师事务所、董事及高管薪酬相关议案，以及对外出租部分闲置场地的议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800037798.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688265"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632471625","title":"每周股票复盘：南模生物（688265）Q1净利同比增170.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632471625","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632471625?lang=zh_cn&edition=full","pubTime":"2026-05-02 07:18","pubTimestamp":1777677493,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，南模生物报收于41.4元，较上周的41.91元下跌1.22%。本周关注点来自业绩披露要点：南模生物2026年一季度归母净利润68.36万元，同比上升170.71%。股本股东变化股东户数变动截至2026年3月31日，南模生物股东户数为6840.0户，较2025年12月31日增加172.0户，增幅2.58%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200003842.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688265","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632066010","title":"南模生物（688265）2026年一季报简析：营收净利润同比双双增长，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2632066010","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632066010?lang=zh_cn&edition=full","pubTime":"2026-05-01 06:48","pubTimestamp":1777589303,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期南模生物发布2026年一季报。截至本报告期末，公司营业总收入9991.71万元，同比上升13.03%，归母净利润68.36万元，同比上升170.71%。本报告期南模生物盈利能力上升，毛利率同比增幅10.15%，净利率同比增幅162.56%。本次财报公布的各项数据指标表现尚佳。去年的净利率为7.47%，算上全部成本后，公司产品或服务的附加值一般。2023年公司在美国购置房产设立美国基地，强化本地化服务能力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050100007242.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688265"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631693687","title":"南模生物（688265）披露2026年第一季度报告，4月30日股价下跌0.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631693687","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631693687?lang=zh_cn&edition=full","pubTime":"2026-04-30 18:07","pubTimestamp":1777543636,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，南模生物报收于41.4元，较前一交易日下跌0.05%，最新总市值为32.28亿元。该股当日开盘41.3元，最高42.06元，最低41.3元，成交额达2002.21万元，换手率为0.62%。公司于2026年4月30日披露《2026年第一季度报告》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000058551.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688265"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631522596","title":"南模生物(688265)3月31日股东户数0.68万户，较上期增加2.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631522596","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631522596?lang=zh_cn&edition=full","pubTime":"2026-04-29 17:43","pubTimestamp":1777455785,"startTime":"0","endTime":"0","summary":"证券之星消息，近日南模生物披露，截至2026年3月31日公司股东户数为6840.0户，较12月31日增加172.0户，增幅为2.58%。在医疗服务行业个股中，南模生物股东户数低于行业平均水平，截至3月31日，医疗服务行业平均股东户数为4.91万户。从股价来看，2025年12月31日至2026年3月31日，南模生物区间涨幅为0.05%，在此期间股东户数增加172.0户，增幅为2.58%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900055397.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688265"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630393304","title":"南模生物（688265）披露2025年度利润分配方案的公告，4月27日股价下跌1.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630393304","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630393304?lang=zh_cn&edition=full","pubTime":"2026-04-27 19:05","pubTimestamp":1777287950,"startTime":"0","endTime":"0","summary":"截至2026年4月27日收盘，南模生物报收于41.1元，较前一交易日下跌1.93%，最新总市值为32.04亿元。该股当日开盘41.98元，最高41.98元，最低39.58元，成交额达4269.03万元，换手率为1.36%。公司于近日披露《2025年度利润分配方案的公告》。公告显示，南模生物2025年度实现归属于母公司所有者的净利润31,436,529.76元，截至2025年12月31日，合并报表累计未分配利润为108,775,039.77元。该方案尚需提交2025年年度股东会审议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700036194.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688265"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630302053","title":"股市必读：南模生物年报 - 第四季度单季净利润同比下降78.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630302053","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630302053?lang=zh_cn&edition=full","pubTime":"2026-04-27 09:15","pubTimestamp":1777252502,"startTime":"0","endTime":"0","summary":"来自：南模生物2025年归母净利润3143.65万元，同比上升383.97%。 近日南模生物披露，截至2026年3月31日公司股东户数为6840.0户，较12月31日增加172.0户，增幅为2.58%。 上海南方模式生物科技股份有限公司2025年度实现归属于母公司所有者的净利润31,436,529.76元，截至2025年12月31日，合并报表累计未分配利润为108,775,039.77元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260427/32178320.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["688265"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630663381","title":"图解南模生物年报：第四季度单季净利润同比下降78.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630663381","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630663381?lang=zh_cn&edition=full","pubTime":"2026-04-26 16:36","pubTimestamp":1777192602,"startTime":"0","endTime":"0","summary":"证券之星消息，南模生物2025年年报显示，当年度公司主营收入4.21亿元，同比上升10.44%；归母净利润3143.65万元，同比上升383.97%；扣非净利润873.16万元，同比上升156.3%；其中2025年第四季度，公司单季度主营收入1.18亿元，同比上升1.66%；单季度归母净利润467.16万元，同比下降78.46%；单季度扣非净利润-154.63万元，同比下降109.23%；负债率13.83%，投资收益177.52万元，财务费用204.37万元，毛利率51.69%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600010154.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688265"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628751189","title":"每周股票复盘：南模生物（688265）审议2026年员工持股计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2628751189","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628751189?lang=zh_cn&edition=full","pubTime":"2026-04-19 03:56","pubTimestamp":1776542168,"startTime":"0","endTime":"0","summary":"本周关注点公司公告汇总：南模生物召开2026年第三次临时股东会，审议通过2026年员工持股计划及相关议案。公司公告汇总上海南方模式生物科技股份有限公司于2026年4月15日召开2026年第三次临时股东会，审议通过《2026年员工持股计划（草案）》及其摘要、《2026年员工持股计划管理办法》、授权董事会办理员工持股计划相关事宜，以及修订《公司章程》及部分治理制度的议案。中小投资者对员工持股计划相关议案进行了单独计票。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041900001343.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688265","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627923338","title":"南模生物（688265）披露2026年员工持股计划相关议案获临时股东会通过，4月15日股价下跌0.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2627923338","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627923338?lang=zh_cn&edition=full","pubTime":"2026-04-15 22:25","pubTimestamp":1776263113,"startTime":"0","endTime":"0","summary":"截至2026年4月15日收盘，南模生物报收于43.79元，较前一交易日下跌0.02%，最新总市值为34.14亿元。近日，上海南方模式生物科技股份有限公司召开2026年第三次临时股东会，审议通过了《2026年员工持股计划（草案）》及其摘要、《2026年员工持股计划管理办法》、授权董事会办理员工持股计划相关事宜以及修订《公司章程》及部分治理制度的议案。中小投资者对员工持股计划相关议案进行了单独计票。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041500043204.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688265","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614831044","title":"南模生物：2025年度净利润同比增长399.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614831044","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614831044?lang=zh_cn&edition=full","pubTime":"2026-02-27 18:11","pubTimestamp":1772187060,"startTime":"0","endTime":"0","summary":"每经AI快讯，2月27日，南模生物公告称，2025年营业总收入42,125.86万元，同比增长10.50%；归母净利润3,243.13万元，同比增长399.29%。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-02-27/doc-inhphcxh3644765.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-02-27/doc-inhphcxh3644765.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688265"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607044137","title":"南模生物：预计2025年全年扣非后净利润盈利650万元至950万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607044137","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607044137?lang=zh_cn&edition=full","pubTime":"2026-01-29 16:48","pubTimestamp":1769676511,"startTime":"0","endTime":"0","summary":"证券之星消息，南模生物发布业绩预告，预计2025年全年扣非后净利润盈利650万元至950万元。南模生物2025年三季报显示，前三季度公司主营收入3.03亿元，同比上升14.29%；归母净利润2676.49万元，同比上升276.14%；扣非净利润1027.79万元，同比上升131.85%；其中2025年第三季度，公司单季度主营收入1.07亿元，同比上升21.52%；单季度归母净利润859.75万元，同比上升242.07%；单季度扣非净利润436.36万元，同比上升137.44%；负债率10.38%，投资收益147.57万元，财务费用145.38万元，毛利率52.87%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900027348.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688265"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605614864","title":"南模生物跌3.17% 2021年上市即巅峰募16.5亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605614864","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605614864?lang=zh_cn&edition=full","pubTime":"2026-01-22 17:25","pubTimestamp":1769073904,"startTime":"0","endTime":"0","summary":"中国经济网北京1月22日讯 南模生物 今日股价下跌，收报48.21元，跌幅3.17%。 南模生物于2021年12月28日在上交所科创板上市，发行股票数量为1949.09万股，发行价格为84.62元/股，保荐人为海通证券股份有限公司，保荐代表人为张子慧、陈亚聪。 南模生物上市首日盘中最高价报82.00元，为该股上市以来最高价。南模生物最终募集资金净额比原计划多10.68亿元。 南模生物首次公开发行股票的发行费用总额为1.81亿元，其中，保荐及承销费用1.58亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260122/31964213.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0216","688265"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604923181","title":"每周股票复盘：南模生物（688265）现溢价13.95%大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2604923181","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604923181?lang=zh_cn&edition=full","pubTime":"2026-01-18 02:55","pubTimestamp":1768676110,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘，南模生物报收于48.58元，较上周的46.87元上涨3.65%。本周，南模生物1月14日盘中最高价报58.78元。交易信息汇总1月12日南模生物发生1笔溢价13.95%的大宗交易，合计成交1514.59万元。公司公告汇总上海南方模式生物科技股份有限公司于2026年1月16日召开2026年第一次临时股东会，审议通过《关于参与投资策源一期基金暨关联交易的议案》。议案获普通股股东同意票占比99.9173%，中小投资者同意票占比91.3333%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011800000668.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688265"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1781178087226,"stockEarnings":[{"period":"1week","weight":-0.0645},{"period":"1month","weight":-0.25},{"period":"3month","weight":-0.2796},{"period":"6month","weight":-0.2169},{"period":"1year","weight":0.1511},{"period":"ytd","weight":-0.2217}],"compareEarnings":[{"period":"1week","weight":-0.0222},{"period":"1month","weight":-0.0549},{"period":"3month","weight":-0.0329},{"period":"6month","weight":0.0267},{"period":"1year","weight":0.1797},{"period":"ytd","weight":0.0061}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海南方模式生物科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"6840人(较上一季度增加2.58%)","perCapita":"11398股","listingDate":"2021-12-28","address":"上海市浦东新区琥珀路63弄1号6层","registeredCapital":"7796万元","survey":" 上海南方模式生物科技股份有限公司的主营业务是基因修饰动物模型的研发、生产、销售和技术服务业务。公司的主要产品是定制化模型、标准化模型、模型繁育、药物评价及表型分析、饲养服务。","listedPrice":84.62},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"南模生物(688265)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供南模生物(688265)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"南模生物,688265,南模生物股票,南模生物股票老虎,南模生物股票老虎国际,南模生物行情,南模生物股票行情,南模生物股价,南模生物股市,南模生物股票价格,南模生物股票交易,南模生物股票购买,南模生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"南模生物(688265)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供南模生物(688265)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}